logo
Takeda’sZasocitinibLandmarkPhase3PlaquePsoriasisDataShowPromisetoDeliverClearSkininaOnce-DailyPill,CatalyzingaNewEraofTreatment
===2025/12/19 9:50:40===
als.gov Identifier: NCT06254950. Updated November 21, 2025. Accessed: December 2025.https://www.clinicaltrials.gov/study/NCT06254950.

A Takeda Presentation. Quarterly Results - Quarter 1 FY2025. Available at:https://assets-dam.takeda.com/image/upload/v1753839858/Global/Investor/Financial-Results/FY2025/Q1/qr2025_q1_p01_en.pdf. Accessed December 2025.

Dhabale A, Nagpure S. Types of psoriasis and their effects on the immune system.Cureus. 2022 Sep 24;14(9):e29536. doi: 10.7759/cureus.29536.

Gkini MA, Nakamura M, Alexis AF, et al. Psoriasis in People With Skin of Color: An Evidence-Based Update.Int J Dermatol. 2025;64(4):667-677. doi:10.1111/ijd.17651

Taliercio VL, Snyder AM, Webber LB, et al. The Disruptiveness of Itchiness from Psoriasis: A Qualitative Study of the Impact of a Single Symptom on Quality of Life.J Clin Aesthet Dermatol. 2021;14(6):42-48.

Snyder AM, Taliercio VL, Webber LB, et al. The Role of Pain in the Lives of
=*=*=*=*=*=
当前为第16/20页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页